ARTV compared with ALXO: revenue, margins and what each company keeps, and the suppliers and customers both name

ARTVArtiva Biotherapeutics, Inc.

Mkt capRevenueRevenue

ALXOALX Oncology Holdings Inc

Mkt capRevenueRevenue

Compare

ARTVArtiva Biotherapeutics, Inc.

ALXOALX Oncology Holdings Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ARTV2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Oct 27 '26±76.2%▼−30.68%×0.40

Q2 FY26±35.1%▼−2.68%×0.08

ALXO1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±51.4%▲+9.90%×0.19

= impliedARTV realized, solidALXO realized, hatchedOne scale, both sides: full bar = 77%× = |realized| ÷ impliedSource: market data

ARTVArtiva Biotherapeutics, Inc.

4.19▲+0.06%

Mkt cap$204.8MRevenue$251,000Q1 FY24

ALXOALX Oncology Holdings Inc

1.29▼−5.84%

Regular sessionNov 3 '26

Mkt cap$189.4MRevenue—

Compare

Regular sessionNov 3 '26

ARTVArtiva Biotherapeutics, Inc.

ALXOALX Oncology Holdings Inc

4.19▲+0.06%

Price

1.29▼−5.84%

$204.8M

Mkt cap

$189.4M

Q1 FY24$251,000

Revenue

—

ARTV4.19▲+0.06%vsALXO1.29▼−5.84%Regular sessionNov 3 '26